ABINGDON, Britain (AP) _ Oxford Immunotec Global PLC (OXFD) on Thursday reported a loss of $1.5 million in its first quarter.
On a per-share basis, the Abingdon, Britain-based company said it had a loss of 6 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.
The immunology diagnostics company posted revenue of $14.8 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $13.9 million.
Oxford Immunotec expects full-year revenue in the range of $69 million to $72 million.
Oxford Immunotec shares have increased 27% since the beginning of the year. The stock has climbed 21% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OXFD at https://www.zacks.com/ap/OXFD